Skip to content

Home
About Us
- Board of Directors
- Management Team
Technology
News/Resources
Investor Centre
Contacts

Audrey Thomson

R&D Tax Incentive

19 March 2020 by Audrey Thomson

R&D Tax Incentive

Categories 2020, ASX Announcements

Presentation to Conference on Retroviral and Opportunistic Infections (CROI) 2020

12 March 2020 by Audrey Thomson

Presentation to Conference on Retroviral and Opportunistic Infections (CROI) 2020

Categories Scientific Presentations

BIT225 Restores Immune Function in HIV-1 Infections

12 March 202012 March 2020 by Audrey Thomson

BIT225 Restores Immune Function in HIV-1 Infections

Categories 2020, ASX Announcements

Half-year Report 31 December 2019

27 February 2020 by Audrey Thomson

Half-year Report 31 December 2019

Categories 2020, ASX Announcements, Half-year reports

February 2020 edition of BITNews

25 February 2020 by Audrey Thomson

February 2020 edition of BITNews

Categories Newsletters

Shareholder Update

25 February 2020 by Audrey Thomson

Shareholder Update

Categories 2020, ASX Announcements

Biotron to Test its Compounds Against Coronavirus

6 February 2020 by Audrey Thomson

Biotron to Test its Compounds Against Coronavirus

Categories 2020, ASX Announcements

Biotron featured on CommSec – January 2020

5 February 20204 February 2020 by Audrey Thomson

January 2020 – Dr Michelle Miller, Biotron Managing Director, interview on CommSec

Categories Biotron in the media

Appendix 3B – New Issue Announcement

31 January 202031 January 2020 by Audrey Thomson

Appendix 3B – New Issue Announcement

Categories 2020, ASX Announcements

Biotron featured on Proactive Investors Australia – January 2020

30 January 2020 by Audrey Thomson

January 2020 – Dr Michelle Miller, Biotron Managing Director, interview on Proactive Investors Australia

Categories Biotron in the media

Post navigation

Older posts

1 2 … 21 Next →

© Biotron Limited 2016 ABN 60 086 399 144 Site updated 1 April 2020 Legal Notices and Privacy